Found 8 resultsAuthor [ Title] Type Year
Filters: Author is Kaleebu, P [Clear All Filters]
“Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events”, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-638, 2012.,
“CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa”, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.,
“A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
“A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant Adeno-Associated Virus HIV Vaccine”, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.,
“A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus”, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.,
“Safety and immunogenicity of HIV-1 clade A vaccines in healthy, HIV uninfected adult Ugandan volunteers”, 2004.,